Absence of tumour necrosis factor facilitates primary and recurrent herpes simplex virus-1 infections

References

1. Cantin E. M., Hinton D. R., Chen J., Openshaw H. 1995; Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J Virol 69:4898–4905
   [Google Scholar]
2. Chen S. H., Garber D. A., Schaffer P. A., Knipe D. M., Coen D. M. 2000; Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation. Virology 278:207–216
   [Google Scholar]
3. Feldman L. T., Ellison A. R., Voytek C. C., Yang L., Krause P., Margolis T. P. 2002; Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci U S A 99:978–983
   [Google Scholar]
4. Fox D. A. 2000; Cytokine blockade as a new strategy to treat rheumatoid arthritis: inhibition of tumor necrosis factor. Arch Intern Med 160:437–444
   [Google Scholar]
5. Gardam M. A., Keystone E. C., Menzies R., Manners S., Skamene E., Long R., Vinh D. C. 2003; Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 3:148–155
   [Google Scholar]
6. Ghiasi H., Perng G., Nesburn A. B., Wechsler S. L. 1999; Either a CD4⁺ or CD8⁺ T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice. Microb Pathog 27:387–394
   [Google Scholar]
7. Halford W. P., Gebhardt B. M., Carr D. J. 1996; Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J Immunol 157:3542–3549
   [Google Scholar]
8. Herbein G., O'Brien W. A. 2000; Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. Proc Soc Exp Biol Med 223:241–257
   [Google Scholar]
9. Hirano T. 1998; Interleukin-6. In The Cytokine Handbook . , 3rd edn. pp  197–228 Edited by Thomson A. San Diego: Academic Press;
10. Jones C. 2003; Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clin Microbiol Rev 16:79–95
    [Google Scholar]
11. Kasahara S., Ando K., Saito K. 7 other authors 2003; Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes. J Virol 77:2469–2476
    [Google Scholar]
12. Koelle D. M., Corey L. 2003; Recent progress in herpes simplex virus immunobiology and vaccine research. Clin Microbiol Rev 16:96–113
    [Google Scholar]
13. Kriesel J. D., Gebhardt B. M., Hill J. M., Maulden S. A., Hwang I. P., Clinch T. E., Cao X., Spruance S. L., Araneo B. A. 1997; Anti-interleukin-6 antibodies inhibit herpes simplex virus reactivation. J Infect Dis 175:821–827
    [Google Scholar]
14. LeBlanc R. A., Pesnicak L., Cabral E. S., Godleski M., Straus S. E. 1999; Lack of interleukin-6 (IL-6) enhances susceptibility to infection but does not alter latency or reactivation of herpes simplex virus type 1 in IL-6 knockout mice. J Virol 73:8145–8151
    [Google Scholar]
15. Liu T., Tang Q., Hendricks R. L. 1996; Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J Virol 70:264–271
    [Google Scholar]
16. Liu T., Khanna K. M., Chen X., Fink D. J., Hendricks R. L. 2000; CD8⁺ T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med 191:1459–1466
    [Google Scholar]
17. Liu T., Khanna K. M., Carriere B. N., Hendricks R. L. 2001; Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J Virol 75:11178–11184
    [Google Scholar]
18. Minagawa H., Yanagi Y. 2000; Latent herpes simplex virus-1 infection in SCID mice transferred with immune CD4+ T cells: a new model for latency. Arch Virol 145:2259–2272
    [Google Scholar]
19. Minagawa H., Tanaka S., Toh Y., Mori R. 1994; Detection of herpes simplex virus type 1-encoded RNA by polymerase chain reaction: different pattern of viral RNA detection in latently infected murine trigeminal ganglia following in vitro or in vivo reactivation. J Gen Virol 75:647–650
    [Google Scholar]
20. Minagawa H., Sakai Y., Li Y. Y., Ishibashi T., Inomata H., Mori R. 1997; Suppression of infectious virus spread and corneal opacification by the combined use of recombinant interferon beta and interleukin-10 following corneal infection with herpes simplex virus-1 in mice. Antiviral Res 36:99–105
    [Google Scholar]
21. Minami M., Kita M., Yan X. Q., Yamamoto T., Iida T., Sekikawa K., Iwakura Y., Imanishi J. 2002; Role of IFN-gamma and tumor necrosis factor-alpha in herpes simplex virus type 1 infection. J Interferon Cytokine Res 22:671–676
    [Google Scholar]
22. Noisakran S., Carr D. J. 1999; Lymphocytes delay kinetics of HSV-1 reactivation from in vitro explants of latent infected trigeminal ganglia. J Neuroimmunol 95:126–135
    [Google Scholar]
23. Pasparakis M., Alexopoulou L., Episkopou V., Kollias G. 1996; Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 184:1397–1411
    [Google Scholar]
24. Rossol-Voth R., Rossol S., Schutt K. H., Corridori S., de Cian W., Falke D. 1991; In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1. J Gen Virol 72:143–147
    [Google Scholar]
25. Schmitt D. A., Sasaki H., Pollard R. B., Suzuki F. 1992; Antiviral effects of recombinant human tumor necrosis factor-alpha in combination with natural interferon-beta in mice infected with herpes simplex virus type 1. Antiviral Res 19:347–352
    [Google Scholar]
26. Shimeld C., Whiteland J. L., Williams N. A., Easty D. L., Hill T. J. 1997; Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1. J Gen Virol 78:3317–3325
    [Google Scholar]
27. Shimeld C., Easty D. L., Hill T. J. 1999; Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: an in vivo study of virus antigen and cytokines. J Virol 73:1767–1773
    [Google Scholar]
28. Trevejo J. M., Marino M. W., Philpott N., Josien R., Richards E. C., Elkon K. B., Falck-Pedersen E. 2001; TNF-alpha-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection. Proc Natl Acad Sci U S A 98:12162–12167
    [Google Scholar]
29. Wagner E. K., Bloom D. C. 1997; Experimental investigation of herpes simplex virus latency. Clin Microbiol Rev 10:419–443
    [Google Scholar]
30. Walev I., Podlech J., Falke D. 1995; Enhancement by TNF-alpha of reactivation and replication of latent herpes simplex virus from trigeminal ganglia of mice. Arch Virol 140:987–992
    [Google Scholar]
31. White D. W., Badovinac V. P., Kollias G., Harty J. T. 2000; Cutting edge: antilisterial activity of CD8⁺ T cells derived from TNF-deficient and TNF/perforin double-deficient mice. J Immunol 165:5–9
    [Google Scholar]
32. Whitley R. J. 2001; Herpes simplex viruses. In Fields Virology , 4th edn. pp  2461–2509 Edited by Knipe D., Howley P. Philadelphia: Lippincott Williams & Wilkins;
    [Google Scholar]
33. Wong G. H. W., Goeddel D. V. 1986; Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature 323:819–822
    [Google Scholar]
34. Zhang M., Tracey K. J. 1998; Tumor necrosis factor. In The Cytokine Handbook , 3rd edn. pp  517–548 Edited by Thomson A. San Diego: Academic Press;
    [Google Scholar]